This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Evaluation of the Effectiveness of a Product Containing Topical Hydrocortisone in the Treatment of Seborrheic Dermatitis of the Face (13244/2009)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2009 by Allergisa Pesquisa Dermato-Cosmetica LTDA.
Recruitment status was:  Not yet recruiting
Information provided by:
Allergisa Pesquisa Dermato-Cosmetica LTDA Identifier:
First received: November 30, 2009
Last updated: December 1, 2009
Last verified: December 2009

Clinical single-blind randomized comparison with the overall objective of evaluating the clinical efficacy of the products Nutracort lotion and Nutracort cream in the treatment of seborrheic dermatitis on the face.

Will be held clinical and perceived efficacy assessment and instrumental measurements. Each product will be applied at half face for 7 consecutive days and all applications will be monitored in the research site. 60 volunteers will be recruited.

Evaluations will be held at the following times: T0 - before the initial application of the product; T1 - 24 hours after starting treatment, T2 - 48 hours after starting treatment, T3 - 72 hours after initiation of treatment, T4 - 96 hours after the start treatment, T7 - 7 days after initiation of treatment.

Seborrheic Dermatitis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Avaliação da eficácia de um Produto de Uso tópico Contendo Hidrocortisona no Tratamento de Dermatite seborréica na Face.

Resource links provided by NLM:

Further study details as provided by Allergisa Pesquisa Dermato-Cosmetica LTDA:

Estimated Enrollment: 60
Study Start Date: April 2010

Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Healthy subjects with seborrheic dermatitis on both sides of the face, both sexes, aged 18 to 60 years, skin types I through IV.

Inclusion Criteria:

  • Healthy subjects
  • Subjects with seborrheic dermatitis on both sides of the face
  • both sexes
  • aged 18 to 60 years
  • skin types I through IV.

Exclusion Criteria:

  • pregnancy / lactation
  • skin condition in the area of application of the product
  • diabetes
  • immune insufficiency
  • subjects that are using systemic corticoids
  • subjects that are using immunosuppressors
  • skin diseases: vitiligo, psoriasis, lupus, atopic dermatitis
  • history of reaction to the product category
  • other diseases or medications that might interfere directly in the study or endanger the health of the subject
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Douglas - P&D, Galderma Identifier: NCT01024374     History of Changes
Other Study ID Numbers: All-E-M-13244-01/02-10-09
Study First Received: November 30, 2009
Last Updated: December 1, 2009

Additional relevant MeSH terms:
Dermatitis, Seborrheic
Skin Diseases
Sebaceous Gland Diseases
Skin Diseases, Eczematous
Skin Diseases, Papulosquamous processed this record on August 18, 2017